Cannabis rescheduling
Cannabis rescheduling · page 4
- Uncategorized
Poll Shows 96% of Cannabis Consumers Distrust DEA’s Role in Rescheduling Debate
Two weeks after the shock suspension of proceedings in the landmark cannabis rescheduling process, it appears the US public believes it was the correct choice.
- Uncategorized
DEA Requests Subpoenas to ‘Compel’ FDA Experts to Give Testimony on Cannabis Rescheduling, Amid Accusations It Is Trying to Overwhelm the Process
The US Drug Enforcement Administration (DEA) has formally requested that the Food and Drug Administration be ‘compelled’ by the court to give evidence at the upcoming cannabis rescheduling hearings.
- Uncategorized
Motion to Remove DEA as Proponent of Cannabis Rescheduling Hearing Dismissed by Judge
As the DEA releases new details about the highly anticipated preliminary rescheduling hearing next week, efforts to remove the DEA as a ‘proponent’ of rescheduling have been dismissed by a judge.
- Uncategorized
DEA Accused of ‘Stacking the Deck’ Against Rescheduling in Hearing Selection
US cannabis rescheduling has come under yet more controversy this week as the US Drug Enforcement Administration (DEA) has been accused of stacking participants with opponents of cannabis reform.
- Uncategorized
Cannabis Rescheduling Hearing Delayed Until Next Year
Just days after announcing the first tranche of witnesses for the critical upcoming public hearing on cannabis rescheduling, the Drug Enforcement Administration (DEA) has postponed it until early 2025.
- Uncategorized
DEA Begins Selecting Witnesses Ahead of Critical Cannabis Rescheduling Trial
The US Drug Enforcement Administration (DEA) has announced the first witnesses due to attend the critical upcoming public hearing on cannabis rescheduling.
- Uncategorized
Rescheduling Delay Sends Cannabis Stocks Into Tailspin
News that the US Drug Enforcement Administration (DEA) is set to host a public administrative hearing on cannabis rescheduling has immediately impacted cannabis stocks.
- Uncategorized
Cannabis Rescheduling Faces Delays as DEA Schedules Post-Election Hearing
Cannabis rescheduling will now likely be delayed until next year as the US Drug Enforcement Administration (DEA) confirmed its plans to hold a hearing on the proposal after the election.
- Uncategorized
Cannabis Rescheduling Challenged by Lawmakers as Future of Project Looks Likely to Depend on Election Outcome
Two Republican lawmakers are questioning the Biden administration’s proposed rescheduling of cannabis, citing concerns over the process.
- Uncategorized
Cannabis Rescheduling Enters Next Phase as Comment Period Closes
The deadline for public comments on the proposed rescheduling of cannabis in the US has now passed, with the Drug Enforcement Administration (DEA) receiving more than 40,000 submissions over the last 60 days.
- Uncategorized
DEA Administrator Allegedly Absent from Cannabis Rescheduling Decision
Reports from last week suggesting that the US Drug Enforcement Administration (DEA) would support recommendations for cannabis rescheduling were not approved by the organization’s administrator, one source has suggested.
- Uncategorized
Anti-Cannabis Group Prepares Legal Challenge to DEA’s Cannabis Rescheduling
Just days after reports suggested that the US Drug Enforcement Administration (DEA) will support recommendations to reschedule cannabis, anti-reform groups have launched a campaign aimed at stopping it in its tracks.
